| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Fractyl Health (NASDAQ:GUTS) will release its quarterly earnings report on Tuesday, 2025-08-12. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Fractyl Health to report an earnings per share (EPS) of $-0.36.
Investors in Fractyl Health are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
In the previous earnings release, the company beat EPS by $0.01, leading to a 13.28% drop in the share price the following trading session.
Here's a look at Fractyl Health's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.50 | -0.44 | -0.50 | -0.46 |
| EPS Actual | -0.49 | -0.52 | -0.48 | -0.36 |
| Price Change % | -13.0% | -4.0% | -2.0% | 5.0% |
Shares of Fractyl Health were trading at $0.9614 as of August 08. Over the last 52-week period, shares are down 57.71%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Fractyl Health visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: GUTS
